Eli Lilly And Stock Today

LLY Stock   28.58  0.32  1.13%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
Eli Lilly is selling at 28.58 as of the 22nd of December 2024; that is 1.13% up since the beginning of the trading day. The stock's open price was 28.26. Eli Lilly has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of December 2024. Click here to learn more.
Category
Healthcare
Eli Lilly is entity of Canada. It is traded as Stock on NEO exchange. More on Eli Lilly and

Moving together with Eli Stock

  0.84RHC Royal HeliumPairCorr
  0.85VGZ Vista GoldPairCorr
  0.86TGO TeraGo IncPairCorr

Moving against Eli Stock

  0.86LMN Lumine GroupPairCorr
  0.84MXG Maxim Power CorpPairCorr
  0.77TSLA Tesla Inc CDRPairCorr
  0.77PRL Propel HoldingsPairCorr
  0.67IMP Intermap TechnologiesPairCorr
  0.67TFII TFI InternationalPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Eli Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Eli Lilly's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Eli Lilly or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO ChairmanDavid Ricks
Business ConcentrationDrug Manufacturers - General, Healthcare, Drug Manufacturers - General, Healthcare (View all Sectors)
Eli Lilly and (LLY) is traded on NEO Exchange in Canada and employs 43,000 people. The company operates under Healthcare sector and is part of Drug Manufacturers - General industry.
Check Eli Lilly Probability Of Bankruptcy

Eli Lilly Risk Profiles

Although Eli Lilly's alpha and beta are two of the key measurements used to evaluate Eli Lilly's performance over the market, the standard measures of volatility play an important role as well.

Eli Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Eli Lilly without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Global Markets Map Now

   

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module

Eli Lilly Corporate Management

Elected by the shareholders, the Eli Lilly's board of directors comprises two types of representatives: Eli Lilly inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Eli. The board's role is to monitor Eli Lilly's management team and ensure that shareholders' interests are well served. Eli Lilly's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Eli Lilly's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ilya YuffaEVP InternationalProfile
Alonzo WeemsEVP OfficerProfile
Gordon BrooksController VPProfile
Anat JDGeneral VPProfile
Jacob NaardenExecutive LoxoProfile
Eric DozierExecutive DiversityProfile
When determining whether Eli Lilly offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.